GenMark Diagnostics, Inc.
(NASDAQ GM: GNMK)
Rigrodsky Law, P.A. is investigating GenMark Diagnostics, Inc. (“GenMark”) regarding possible breaches of fiduciary duties and other violations of law related to GenMark’s agreement to be acquired by Roche Holdings, Inc. Under the terms of the agreement, GenMark’s shareholders will receive $24.05 in cash per share.